Endocrinology Flashcards

(117 cards)

1
Q

Genetic Syndromes of hypokalaemia

A

Barters, Gitelman, Liddles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which genetic syndrome of hypokalaemia is associated with High Blood Pressure

A

Liddles - rare autosomal dominant, gain-of-function mutation in ENaC leads to hereditary hypokalemia and hypertension, mimicking the syndrome of mineralocorticoid excess.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which genetic syndrome of hypokalaemia mimics the action of loop diuretics?

A

Barter Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which genetic causes of hypokalaemia lead to a metabolic alkalosis

A

Barter and Gitelman Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Features of Primary Hyperaldonstoeronism (Conn’s Syndrome)

A

Triad of Hypertension, Hypokalaemia and Metabolic Alkalosis. Excess Hyperaldosterone –> Excess excretion of Potassium (Sodium potassium exchanger in the distal convoluted tubule), metabolic alkalosis and hypertension.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Diagnosis in suspected Primary Hyperaldosteronism

A

Plasma Aldosterone Concentration/Plasma Renin Concentration. If significantly elevated ratio then tends to suggest Primary Aldosteronism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the four factors that increase the likelihood of underlying osteomyelitis in the context of ulcers

A

1) Grossly visible bone or ability to probe to bone
2) Ulcer size >2cm squared
3) Ulcer duration longer that one to two weeks
4) ESR >70

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which finding is specific for Grave’s Disease

A

Pre-tibial Myxodema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Best investigations for Grave’s Disease

A

1) Thyroid Antibodies - TSH receptor antibody

2) Tc 99 scan where there will be symmetrical homogenous uptake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Three treatment modalities for Graves Disease

A

1) Thionamides: Carbimazole/PTU
2) Radioactive Iodine
3) Thyroidectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Side effects of Thionamides

A
Itch
Rash
Agranulocytosis (Neutropenia) 
Hepatotoxicity 
pANCA vasculitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which Thionamide should be used in the first trimester of pregnancy

A

PTU

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which thionamide should be used after the first trimester of pregnancy

A

Carbimazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Addison’s Disease metabolic changes

A

Reduced production of mineralocorticoid therefore hyperkalaemia, hyponatraemia and hypoglycaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Maintenance therapy in primary adrenal insufficiency

A

Glucocorticoids: Can use Hydrocort 15-25 (10mg/m squared) BD/TDS dosing or prednisone 3-5mg
Mineralocorticoid: Fludrocortisone: 100 units per day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cardinal Features of Autoimmune Polyglandular Syndrome Type 1

A

Occurs in children, Addison’s disease associated with mucocutaneous candidiasis and hypoparathyroidism. Autosomal Recessive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Cardinal Features of Autoimmune Polyglandular Syndrome Type 2

A

Addison’s Disease
Type 1 diabetes
Thyroid Disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Gold standard test for Primary Adrenal Insufficiency

A

Insulin Tolerance Test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Investigation of Primary Adrenal Insufficiency

A

Morning cortisol
Short Synacthen Test
Insulin Tolerance Test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Most common deficiency if Congenital Adrenal Hyperplasia

A

21 hydroxylase which leads to an increase in 17 hydroxylase (the precursor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

When should you investigate for Adrenoleukodystrophy? What is the screening test

A

Young males with adrenal insufficiency. Very long chain fatty acids (elevated = diagnosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is gold standard diagnostic test for differentiating between a pituitary or ectopic cause of ACTH dependent Cushing’s syndrome

A

Bilateral Inferior Petrosus Sinus Sampling. Central step up ratio of ACTH central to perisperhal of >2 is diagnostic of pituitary cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Triad of symptoms associated with phaechromocytoma

A

Episodic
Tachycardia
Diaphoresis
Headache

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Genetic Syndromes associated with Phaechromocytoma

A

In order
MEN 2
VHL
NF1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Main Adverse Effect of GLP-1 receptor agonist (Exenatide or Dulaglutide)
1. Nausea + Vomitting - normally transient and improves after 1-2 weeks
26
Contraindications & precautions with Exenatide/Dulaglutide
1. Gastroparesis (delays gastric emptying) 2. History of Pancreatitis with GLP-1 analogue 3. Treatment with oral sulfonylurea or insulin (increases risk of hypo) 4. Gallbladder disease (increase risk of needing a cholecystectomy)
27
Indication for Exenatide/Dulaglutide
HBA1c >7% with dual or triple oral therapy/insulin
28
PBS criteria for commencing anti-osteoperotic therapy in patients on sertoids
1) >7.5 of pred 2) 3 months 3) T score <1.5
29
Bisphosphonates mechanism of action
Binds to surface of bones --> Inhibition of osteoclast activity (loss of ruffled border and induced apoptosis) Targets farnesyl pyrophosphate "paints bone then leads to osteoclast apoptosis)
30
SERM mechanism of action
Selective Estrogen Receptor Modulator - binds to oestrogen receptors Prevents vertebral factures (only) Also decreases the risk of breast cancer
31
Zoledronic Acid adverse effects
Flu like reaction (paracetamol and NSAID's) | ? Atrial Fibrillation
32
Denosumab MOA
Monoclonal antibody that binds RANK ligand preventing osteoclast activation Nb discontinuation or missing of doss --> rapid reduction of bone density (rapid bone resorption). Do not commence in someone who may be non-compliant.
33
Adverse effect of prolonged anti-resorptive therapy
1) Osteonecrosis of the jaw > 8 weeks of exposed alveolar bone after dental extraction 2) Atypical femoral fracture (prodrome with thigh pain). Risk factor is treatment with glucocorticoids.
34
Treatment of Atyipical femur fracture
1) Discontinue anti-resorptive 2) Incomplete - prophylactic nail fixation 3) Complete - orthropods 4) Monitor risk in contralateral hip
35
Potential treatment for refractory osteoporosis
PTH - Skeletal anabolic steroid
36
Effect of irony infusion on phsophate
Loss of phosphate though the kidneys
37
Findings in osteomalacia
1) High ALP 2) Bone pain/fractures 3) myopathy
38
What is osteomalacia caused by
1) Vitamin D Deficiency | 2) Low phosphate
39
Risk factors for Graves disease
1) Family hx of autoimmune thyroid disease 2) Recent iodine exposure 3) Post partum
40
Technetium scan in Graves Disease
Uniform uptake of technetium
41
Mgmt Graves disease
1) Beta Blocker - symptomatic 2) Control hyperthyroidism - Thionamide (adverse effect neutropenia/rash/pANCA vasculitis) - Radioactive iodine (contraindicated in eye disease and can be slow onset) (adverse effect hypothyroidism - Surgery
42
Pathognomic signs of graves disease
1) Pretibial myxoedema | 2) Graves orbitopathy
43
Adverse effects of thionamides
1) Neutropenia 2) Rash 3) pANCA vasculitis PTU: Fulminant inflammatory hepatitis
44
Which thionamide to use in first trimester
PTU "primary trimester"
45
Risk factors for graves orbitopathy
1) Smoking 2) Radioactive iodine 3) Hypothyroidism (through fluid retention)
46
Treatment for grave's orbitopathy
Pulse methylprednisolone Radiotherapy if no response Surgical debunking in the chronic phase
47
Periodic paralysis associated with graves disease precipitant and electrolyte findings
1) Thyrotoxicosis due to graves disease 2) High carbohydrate meal --> insulin 3) Hypokalaemia Below the waist paralysis Seen in patients with Asian heritage
48
Dosing thyroxine in pregnancy
Increase dose by 1.3 times
49
Subclinical hypothyroidism in pregnancy
Give thyroxine during pregnancy
50
Toxic nodule on technetium scan
One major nodule with remainder of the thyroid suppressed
51
Treatment for toxic nodule
Radioactive iodine | trapped in overactive area
52
Treatment for multi nodular goitre
Radioactive iodine
53
Thyroidits on technetium
No uptake + neck tenderness
54
Treatment for thyroiditis
Propanolol for symptoms | NSAID's/pred for pain
55
Amiodarone thyroiditis
1) Type 1: Iodine load | 2) Type 2: Thyroiditis
56
Treatment for amiodarone thyroiditis
1) Thionamides 2) Steroids for thyroiditis 3) Colestyramine to decrease ? intrahepatic flow of thyroid hormones
57
Technetium scan in amiodarone thyroiditis
Cold as amiodarone competes with technetium for uptake.
58
Drugs that can affect the thyroid
1) Amiodarone - Hypothyroidism or thyroiditis 2) Lithium - Hypothyroidism or thyroiditis 3) Immune checkpoint inhibitors - PD-1: primary thyroiditis - Anti-CTLA4: central and secondary hypothyroidism 4) Alemtuzumab - Graves disease common (15% of patients) 5) Interferon alpha 6) Tyrosine kinase inhibitors 7) Bexarotene (cutaneous lymphoma)
59
Which drug used in MS is associated with Grave's disease?
Alemtuzumab
60
Findings in subclinical hypothyroidism
Normal T3/T4 but elevated TSH Treat young and also pregnant Do not treat old
61
Findings in subclinical hypothyroidism
Normal t3/t4 but low TSH Treat old people irrespective Treat young people if very low TSH
62
Commonest type of thyroid cancer
Papillary
63
Thyroid scan on technetium scan
Cold
64
Important first test when working up thyroid nodule?
TSH - helps differentiate toxic nodule from thyroid cancer
65
Tumor marker in follicular derived thyroid cancer
Serum thyroglobulin
66
What is given to facilitate radio-iodine post surgical removal of thyroid cancer
Recombitant TSH
67
Treatment for radio-iodine refractory, surgery inappropriate progressive thyroid cancer
Lenvatinibi - multi targeted kinase inhibitor
68
Most common mutation in medullary thyroid cancer
RET mutation
69
MEN 2A
Phaeo Medullary thyroid cancer Hyperparathyroidism
70
What to exclude in medullary thyroid cancer
Exclude phaeo with 24 hr urinary metanephrines
71
Tumor marker for medullary thyroid cancer
Calcitonin
72
MEN 2B
Marfarnoid habitus Medullated corneal nerves Aerodigestive ganglioneuromas Medullary thyroid cancer
73
Investigation for ACTH deficiency
Insulin tolerance test | --> hypoglycaemia --> ACTH
74
GH deficiency
Insulin tolerance test
75
Pituitary mass clinical features
1) Amenorrhea 2) Visual field defect 3) Occulomotor palsy
76
Most common functioning pituitary adenoma
Porlactinoma
77
Treatment for prolactinoma that does not require surgical intervention
Dopamine agonist: Bromacriptine/Cabergoline
78
What to measure on acromegaly to screen for GH secreting adenoma
IGF-1
79
Medical (pre-surgical) treatment for GH adenoma
Somatostatin analogues.
80
Treatment for Acromegaly post surgery with elevated IGF-1
1) Dopamine agonist 2) Somatostatin analogues 3) Pegvisomant Adverse effects of somatostatin analogies --> diabetes mellitus due to suppressive effects on Beta cells
81
Acromegaly cancer association
1) Thyroid cancer 2) Colon cancer - Colonoscopy from age 40 n
82
Pegvisomant mechanism of action (used in Acromegaly)
Pegvisomant: Blocks growth hormone receptor
83
ACTH excess clinical feature
Hyperpigmentation Easy bruising Wounds that don't heal Spinal osteoporosis
84
Next best test when elevate cortisol identified on test
Coupled cortisol and acth to determine if ACTH dependent or ACTH independent
85
How do you prevent Nelsons syndrome in ACTH excess with adrenalectomy?
Pituitary irradiation
86
Drugs that can be used in Cushing's disease | not complete
1) Ketoconazole | 2) Metyrapone
87
Causes of ectopic ACTH
Small cell lung cancer | Lung Carcinoid
88
Characteristic biochemistry of TSH-oma
Elevated T4/T3 Normal or elevated TSH Ddx: resistant to thyroid hormone
89
Most common presenting symptom of pituitary apoplexy
Headache (between the eyes and acute onset)
90
Most common deficiency in lymphocytic hypophysitis? (two)
ACTH | ADH
91
Measurement for ADH
Copeptin
92
``` Diabetes insipidus (central - under production of ADH) NOT COMPLETE ```
Central - Head injury - Hypohpysitis - Infiltrating lesions - Nephrogenic
93
MEN1 associated diseases
P's 1) Parathyroid 2) Pancreas (neurological-endocrine) 3) Pituitary
94
Pituitary Apoplexy treatment
1) Give steroids -dex 2) Check prolactin/cortisol and other hormones 3) If prolactinaemia then give bromocriptine 4) Surgery
95
HLA -Associated disease in DR4-DQ8 or DR3-DQ2
1) T1DM 2) Autoimmune thyrpoids (screen annually) 3) Coeliac Disease 4) Pernicious Anaemia Other: Addisons disease, ITP, Polyglandular autoimmune syndrome type 2, RA, vitiligo and autoimmune hepatitis
96
Markers of Beta cell autoimmunity - Autoantibodies in T1DM
Pro-insulin - beta cell specific GAD IA-2 Zinc Transporter 8 - beta cell specific
97
Benefits of insulin glargine
1) Improvements in HBA1c 2) Less nocturnal hypoglycaemia Nb: Toujeo is associated with reduced severe hypoglycaemia
98
Diagnostic criteria for LADA
1) Diabetes 2) Adult 3) Evidence of islet cell autoimmunity: GAD antibodies > 5 units 4) Quick progression to insulin after initial period of insulin independence
99
Potential clinical features of LADA
``` Age <50 Acute symptoms at onset BMI <25 Personal autoimmune history Family autoimmune history ```
100
Diagnostic criteria in T2DM in asymptomatic patients
1) HbA1c ≥6.5% (48 mmol/mol) on two separate occasions or 2) FBG ≥7.0 mmol/L or random blood glucose ≥11.1 mmol/L confirmed by a second abnormal FBG on a separate day or 3) OGTT before (fasting) and two hours after an oral 75 g glucose load is taken. Diabetes is diagnosed as FBG ≥7.0 mmol/L or two-hour post-challenge blood glucose ≥11.1 mmol/L
101
Indication to commence GLP-1 agonist (exenatide/dulalgutide/semaglutide)
1) HBA1c > 7% 2) Dual or triple oral therapy or insulin Weight loss ? Cardiovascular improvement in outcomes
102
DPP-4 inhibitors (Gliptins)
Adverse effect: ?Pancreatitis (Cannot use if previous pancreatitis) Weight neutral
103
Best gliptin to use in renal failure
Linaglipitin
104
SGLT2 site of action
Proximal tubule
105
Contraindication for SGLT2
1) Renal impairment GFR <45 2) Hepatic impairment 3) ? Elderly
106
Interactions of SGLT2
Loop diuretics
107
Adverse effects of SGLT2
1) Polyuria 2) Genital infection - 5% 3) Hypoglycaemia (only in combo with insulin/OS) 4) Euglycaemia DKA (precipitants surgery - w/h 72 hours prior, fasting and ketogenic diets, sever intercurrent illness with reduction in oral intake, underlying autoimmune diabetes)
108
Most sensitive test for early peripheral neuropathy in DM?
128 Hz tuning fork
109
Predictor of cardiovascular death in diabetics
Microalbuminuria (Commence on RAAS agent if found)
110
Which of the incretin drugs is associated with weight loss?
GLP-1 Analogues
111
Main adverse effect of Glitazones
MOA: PPAR agonists | A/E: Heart failure
112
Obesity associated malignancy
1) Endometrial 2) Oesophageal 3) Gall bladder 4) Renal 5) Colon 6) Breast
113
Most prevalent gene associated with human obesity
MC4-R (dominant)
114
Stimulatory signal to the hypothalamus to eat
Ghrelin | ILP-5
115
Is leptin inhibitory or stimulatory?
Inhibitory
116
Medications that can be used for weight loss
1) Phentermine: Sympathomimetic amine 2) Topiramate: Off label 3) Orlistat: Intestinal lipase inhibitor 4) Liragluatide: GLP-1 agonist. 5) Buproprine/Naltrexone: Combined NA/DO reuptake inhibitors and nicotinic receptor antagonist + opined receptor antagonist 6) Lorcaserin: Selective 5HT receptor agonist n
117
Indications for bariatric surgery
``` 1) BMI > 40 with no major comorbidities or 2) BMI > 35 or 3) BMI 30-35 with metabolic syndrome, or uncontrollable T2DM ```